Xontogeny LLC 13D and 13G filings for Landos Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-30 5:27 pm Unchanged | 2023-03-23 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 9.900% | 0 (Unchanged) | Filing |
| 2022-08-09 09:19 am Purchase | 2022-08-09 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 7.700% | 309,092 (New Position) | Filing |